2025-11-16 - Analysis Report
Okay, here's a report analyzing Natera Inc. (NTRA) based on the data provided.

## Natera Inc. (NTRA) Analysis

### 1. Performance vs. S&P 500 (VOO)

*   **Ticker:** NTRA
*   **Company Overview:** Natera Inc. is a diagnostics company specializing in cell-free DNA testing.

**Key Performance Metrics:**

*   **NTRA Cumulative Return:** 110.25%
*   **VOO (S&P 500) Cumulative Return:** 99.28%
*   **Spread (NTRA - VOO):**
    *   Current: 4.5
    *   Max: 174.8
    *   Min: -88.5
    *   Relative Spread: 35.3

**Analysis:** NTRA has outperformed the S&P 500 over the tracked period, but the current spread is relatively low compared to its historical range. The relative spread of 35.3 indicates that the current performance difference is in the lower range of its historical outperformance.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
| :----------- | :------ | :------ | :------ | :----- | :------- |
| 2015-2017  | -10.0%  | 70.1% | -34.0%  | -0.0  | 1.2    |
| 2016-2018  | 22.0%   | 80.0% | 6.0%    | 0.0   | 1.9    |
| 2017-2019  | 50.0%   | 80.0% | 28.0%   | 1.1   | 4.7    |
| 2018-2020  | 186.0%  | 80.5% | 163.0%  | 1.2   | 13.7   |
| 2019-2021  | 96.0%   | 80.5% | 49.0%   | 1.6   | 12.9   |
| 2020-2022  | -77.0%  | 80.5% | -76.0%  | 0.1   | 5.5    |
| 2021-2023  | -194.0% | 76.6% | -195.0% | -1.1  | 8.7    |
| 2022-2024  | 8.0%    | 76.6% | -13.0%  | -1.2  | 21.9   |
| 2023-2025  | 137.0%  | 76.6% | 74.0%   | 0.1   | 28.2   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows volatile performance over the periods, with significant gains in some years and substantial losses in others. The high volatility is evident.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant risk and potential for substantial losses during downturns.
*   **Alpha:** Alpha, which measures performance relative to the benchmark (S&P 500), is highly variable, with some periods showing strong outperformance (positive Alpha) and others showing significant underperformance (negative Alpha).
*   **Beta:** The Beta values fluctuate around 1, indicating that NTRA's volatility is generally in line with the market, but can be negative during certain periods, suggesting it can move inversely to the market.
*   **Cap:** Market capitalization varies over time, reflecting the changing valuation of the company.

### 2. Recent Stock Price Movement

*   **Current Price:** $204.28
*   **Previous Close:** $200.67
*   **Change:** 1.8% (Positive)
*   **5-day Moving Average:** 205.56
*   **20-day Moving Average:** 196.91
*   **60-day Moving Average:** 178.99

**Analysis:** NTRA is currently trading above its 20-day and 60-day moving averages, suggesting a short-term upward trend. The price has risen significantly (+1.8%) compared to the previous close, indicating a recent positive move.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 64.07 (Approaching Overbought)
*   **PPO:** -0.07 (Slightly Below Zero - Bearish Signal)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (5 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-11-03)
*   **20-day Relative Spread Change:** 3.5 (Positive - Short-Term Increase)
*   **Expected Return:** -84.3% (Long-Term Underperformance vs. S&P 500)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI indicates that the stock is nearing overbought territory.
*   The PPO is slightly negative, which could signal a potential bearish trend.
*   The Hybrid Signal suggests aggressive investment (0% cash), but with a relatively small allocation, deemed "very safe."
*   The positive change in relative spread indicates recent short-term outperformance.
*   The significantly negative expected return suggests potential long-term underperformance compared to the S&P 500.
*   The price change of 1.8% indicates a recent upward swing, possibly triggering volatility.

### 4. Recent News & Significant Events

*   **[2025-11-14] Liberty All-Star® Growth Fund, Inc. October 2025 Monthly Update:** A general update from a growth fund. May indirectly influence investor sentiment.
*   **[2025-11-14] Stanley Druckenmiller's Strategic Moves: Exiting Philip Morris International Inc:** Unrelated to NTRA, general market news.
*   **[2025-11-14] Does Natera (NTRA) Have a Long Runway For Growth?:** Positive outlook, suggesting potential for long-term growth.
*   **[2025-11-13] Stocks That May Be Priced Below Intrinsic Value In November 2025:** Potentially positive, suggesting NTRA might be undervalued.
*   **[2025-11-12] Natera Integrates Oncology Tests With Flatiron's Electronic Medical Record Platform:** Positive development, expanding market reach and integration with healthcare systems.
*   **[2025-11-12] Natera Integrates with Flatiron Health’s OncoEMR® Platform:** Same as above, confirms the strategic partnership.

**Analysis:** Recent news is largely positive, highlighting growth prospects and strategic integrations within the healthcare industry. This positive news likely contributes to recent price increases.

#### 4-2 Analyst Opinions

*   **Consensus:** Strong Buy
*   **Mean Rating:** 1.47 (~Strong Buy)
*   **Opinions:** 19
*   **Target Price:**
    *   Avg: 230.89
    *   High: 250.00
    *   Low: 186.00

**Analysis:** Analyst sentiment is strongly positive, with a consensus of "Strong Buy" and an average target price significantly above the current price. This suggests analysts believe the stock is undervalued.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue     |
| :--------- | :------ | :------------ |
| 2025-11-07 | -0.64 | 0.59 B$ |
| 2025-08-08 | -0.74 | 0.55 B$ |
| 2025-05-09 | -0.50 | 0.50 B$ |
| 2024-11-12 | -0.26 | 0.44 B$ |
| 2025-11-07 | -0.26 | 0.44 B$ |

**Analysis:**

*   **EPS:**  Earnings Per Share (EPS) is negative across all reported quarters, indicating that the company is not currently profitable.
*   **Revenue:** Revenue has been generally increasing over the quarters, indicating growth in sales.
*   The EPS has generally decreased over the last quarters.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
| :----------- | :------- | :-------------- |
| 2025-09-30 | $0.59B  | 64.91%       |
| 2025-06-30 | $0.55B  | 63.41%       |
| 2025-03-31 | $0.50B  | 63.12%       |
| 2024-12-31 | $0.48B  | 62.94%       |
| 2024-09-30 | $0.44B  | 61.79%       |

**Capital and Profitability:**

| Quarter      | Equity  | ROE      |
| :----------- | :------- | :--------- |
| 2025-09-30 | $1.25B | -6.99%   |
| 2025-06-30 | $1.25B | -8.10%   |
| 2025-03-31 | $1.24B | -5.40%   |
| 2024-12-31 | $1.20B | -4.50%   |
| 2024-09-30 | $0.88B | -3.60%   |

**Analysis:**

*   **Revenue:**  Revenue is growing consistently quarter over quarter.
*   **Profit Margin:** Profit margin is high and slightly increasing.
*   **Equity:**  Equity is relatively stable.
*   **ROE:**  Return on Equity (ROE) is negative, reflecting the company's lack of profitability.

### 7. Overall Summary

Natera (NTRA) presents a mixed picture.

*   **Positives:**  Positive analyst ratings, strong revenue growth, high profit margins, and recent positive news regarding strategic partnerships suggest potential for future growth.
*   **Negatives:** Negative EPS and ROE indicate current unprofitability. The negative expected return suggests potential long-term underperformance vs. the S&P 500. High MDD values indicate that the stock is very risky.

**Investment Recommendation:**

While analyst consensus is "Strong Buy" and the company is showing revenue growth and positive developments, the negative earnings, high volatility, and negative long-term expected return suggest caution. A long-term investment strategy should be approached carefully, considering the company's current lack of profitability and high-risk profile.
